Literature DB >> 25599148

Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support.

Yu Kawai1, Timothy T Cornell, Elaine G Cooley, Craig N Beckman, Paula K Baldridge, Theresa A Mottes, Kera E Luckritz, Kathryn S Plomaritas, J Michael Meade, Folafoluwa O Odetola, Yong Y Han, Neal B Blatt, Gail M Annich.   

Abstract

OBJECTIVE: To determine the effect of therapeutic plasma exchange on hemodynamics, organ failure, and survival in children with multiple organ dysfunction syndrome due to sepsis requiring extracorporeal life support.
DESIGN: A retrospective analysis.
SETTING: A PICU in an academic children's hospital. PATIENTS: Fourteen consecutive children with sepsis and multiple organ dysfunction syndrome who received therapeutic plasma exchange while on extracorporeal life support from 2005 to 2013.
INTERVENTIONS: Median of three cycles of therapeutic plasma exchange with median of 1.0 times the estimated plasma volume per exchange.
MEASUREMENTS AND MAIN RESULTS: Organ Failure Index and Vasoactive-Inotropic Score were measured before and after therapeutic plasma exchange use. PICU survival in our cohort was 71.4%. Organ Failure Index decreased in patients following therapeutic plasma exchange (mean ± SD: pre, 4.1 ± 0.7 vs post, 2.9 ± 0.9; p = 0.0004). Patients showed improved Vasoactive-Inotropic Score following therapeutic plasma exchange (median [25th-75th]: pre, 24.5 [13.0-69.8] vs post, 5.0 [1.5-7.0]; p = 0.0002). Among all patients, the change in Organ Failure Index was greater for early therapeutic plasma exchange use than late use (early, -1.7 ± 1.2 vs late, -0.9 ± 0.6; p = 0.14), similar to the change in Vasoactive-Inotropic Score (early, -67.5 [28.0-171.2] vs late, -12.0 [7.2-18.5]; p = 0.02). Among survivors, the change in Organ Failure Index was greater among early therapeutic plasma exchange use than late use (early, -2.3 ± 1.0 vs late, -0.8 ± 0.8; p = 0.03), as was the change in Vasoactive-Inotropic Score (early, -42.0 [16.0-76.3] vs late, -12.0 [5.3-29.0]; p = 0.17). The mean duration of extracorporeal life support after therapeutic plasma exchange according to timing of therapeutic plasma exchange was not statistically different among all patients or among survivors.
CONCLUSIONS: The use of therapeutic plasma exchange in children on extracorporeal life support with sepsis-induced multiple organ dysfunction syndrome is associated with organ failure recovery and improved hemodynamic status. Initiating therapeutic plasma exchange early in the hospital course was associated with greater improvement in organ dysfunction and decreased requirement for vasoactive and/or inotropic agents.

Entities:  

Mesh:

Year:  2015        PMID: 25599148      PMCID: PMC4424057          DOI: 10.1097/PCC.0000000000000351

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  36 in total

1.  Understanding the role of von Willebrand factor and its cleaving protease ADAM TS13 in the pathophysiology of critical illness.

Authors:  Trung C Nguyen; Joseph A Carcillo
Journal:  Pediatr Crit Care Med       Date:  2007-03       Impact factor: 3.624

Review 2.  Blood purification and mortality in sepsis: a meta-analysis of randomized trials.

Authors:  Feihu Zhou; Zhiyong Peng; Raghavan Murugan; John A Kellum
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

3.  Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

Authors:  Joseph Schwartz; Jeffrey L Winters; Anand Padmanabhan; Rasheed A Balogun; Meghan Delaney; Michael L Linenberger; Zbigniew M Szczepiorkowski; Mark E Williams; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2013-07       Impact factor: 2.821

4.  A case series of the successful use of ECMO, continuous renal replacement therapy, and plasma exchange for thrombocytopenia-associated multiple organ failure.

Authors:  Brian C Bridges; Daphne Hardison; John Pietsch
Journal:  J Pediatr Surg       Date:  2013-05       Impact factor: 2.545

Review 5.  Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines.

Authors:  Jeffrey L Winters
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

6.  Plasmapheresis for meningococcemia with disseminated intravascular coagulation.

Authors:  W B Scharfman; J R Tillotson; E G Taft; E Wright
Journal:  N Engl J Med       Date:  1979-05-31       Impact factor: 91.245

Review 7.  Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange.

Authors:  Lirong Qu; Joseph E Kiss; Gina Dargo; Joseph A Carcillo
Journal:  J Clin Apher       Date:  2011-07-22       Impact factor: 2.821

8.  Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.

Authors:  R Phillip Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven A Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Crit Care Med       Date:  2013-02       Impact factor: 7.598

9.  Trends in the epidemiology of pediatric severe sepsis*.

Authors:  Mary E Hartman; Walter T Linde-Zwirble; Derek C Angus; R Scott Watson
Journal:  Pediatr Crit Care Med       Date:  2013-09       Impact factor: 3.624

10.  Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.

Authors:  Michael G Gaies; James G Gurney; Alberta H Yen; Michelle L Napoli; Robert J Gajarski; Richard G Ohye; John R Charpie; Jennifer C Hirsch
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

View more
  12 in total

1.  Therapeutic plasma exchange as a strategy to reverse multiple organ dysfunction syndrome in patients receiving extracorporeal life support.

Authors:  Trung C Nguyen; Joseph A Carcillo
Journal:  Pediatr Crit Care Med       Date:  2015-05       Impact factor: 3.624

Review 2.  Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.

Authors:  Allan Doctor; Jerry Zimmerman; Michael Agus; Surender Rajasekaran; Juliane Bubeck Wardenburg; James Fortenberry; Anne Zajicek; Emma Mairson; Katri Typpo
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

3.  [Plasma exchange in treatment refractory septic shock : Presentation of a therapeutic add-on strategy].

Authors:  S David; M M Hoeper; J T Kielstein
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-11-24       Impact factor: 0.840

4.  Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices.

Authors:  Gopal K Patidar; Kevin J Land; Hans Vrielink; Naomi Rahimi-Levene; Eldad J Dann; Hind Al-Humaidan; Steven L Spitalnik; Yashaswi Dhiman; Cynthia So-Osman; Salwa I Hindawi
Journal:  Vox Sang       Date:  2021-03-17       Impact factor: 2.996

5.  Use of Therapeutic Plasma Exchange during Extracorporeal Life Support in Critically Ill Cardiac Children with Thrombocytopenia-Associated Multi-Organ Failure.

Authors:  Mei Chong; Alejandro J Lopez-Magallon; Lucas Saenz; Mahesh S Sharma; Andrew D Althouse; Victor O Morell; Ricardo Munoz
Journal:  Front Pediatr       Date:  2017-12-01       Impact factor: 3.418

6.  Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis.

Authors:  Amanda M McIntosh; Suhong Tong; Sara J Deakyne; Jesse A Davidson; Halden F Scott
Journal:  Pediatr Crit Care Med       Date:  2017-08       Impact factor: 3.624

Review 7.  Adjunctive Therapies During Extracorporeal Membrane Oxygenation to Enhance Multiple Organ Support in Critically Ill Children.

Authors:  Marguerite Orsi Canter; Jessica Daniels; Brian C Bridges
Journal:  Front Pediatr       Date:  2018-04-03       Impact factor: 3.418

Review 8.  Coagulation and Bleeding Management in Pediatric Extracorporeal Membrane Oxygenation: Clinical Scenarios and Review.

Authors:  Lisa A Hensch; Shiu-Ki Rocky Hui; Jun Teruya
Journal:  Front Med (Lausanne)       Date:  2019-01-11

Review 9.  Update on pediatric sepsis: a review.

Authors:  Tatsuya Kawasaki
Journal:  J Intensive Care       Date:  2017-07-20

Review 10.  ECMO for Neonatal Sepsis in 2019.

Authors:  Warwick Wolf Butt; Roberto Chiletti
Journal:  Front Pediatr       Date:  2020-02-21       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.